| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KROS | Common Stock | Options Exercise | $320K | +20K | $16.00 | 20K | Jun 8, 2023 | Direct | F1 | |
| transaction | KROS | Common Stock | Sale | -$825K | -17.3K | -86.51% | $47.66 | 2.7K | Jun 8, 2023 | Direct | F1, F2 |
| transaction | KROS | Common Stock | Sale | -$131K | -2.7K | -100% | $48.65 | 0 | Jun 8, 2023 | Direct | F1, F3 |
| transaction | KROS | Common Stock | Options Exercise | $320K | +20K | $16.00 | 20K | Jun 9, 2023 | Direct | F1 | |
| transaction | KROS | Common Stock | Sale | -$720K | -16K | -79.97% | $45.03 | 4.01K | Jun 9, 2023 | Direct | F1, F4 |
| transaction | KROS | Common Stock | Sale | -$66.3K | -1.43K | -35.64% | $46.46 | 2.58K | Jun 9, 2023 | Direct | F1, F5 |
| transaction | KROS | Common Stock | Sale | -$122K | -2.58K | -100% | $47.25 | 0 | Jun 9, 2023 | Direct | F1, F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KROS | Employee Stock Option (right to buy) | Options Exercise | $0 | -20K | -14.97% | $0.00 | 114K | Jun 8, 2023 | Common Stock | 20K | $16.00 | Direct | F1, F7 |
| transaction | KROS | Employee Stock Option (right to buy) | Options Exercise | $0 | -20K | -17.6% | $0.00 | 93.6K | Jun 9, 2023 | Common Stock | 20K | $16.00 | Direct | F1, F7 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 8, 2023. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.12 to $48.095 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.12 to $48.935 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.995 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.015 to $47.01 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.015 to $47.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F7 | One-fourth (1/4th) of the shares subject to the option shall vest on February 24, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. |